UCLE(UCLE)

$0.04—

Chart

UCLE(UCLE)

OTC

$0.04—

Chart Studio

UCLE(UCLE)

UCLE

Overview Notebook Intelligence Chart History Fundmntls TTM Earnings Analysts News Financials Segments Insiders Institl.DCF Peers

7/20/26

US NUCLEAR (UCLE)

Monday

12:02 PM

Thesis: The recent contract win and potential regulatory changes are expected to drive demand for UCLE's products, improving market sentiment.

Revenue Outlook

Metric	FY2024	FY2025
Revenue	$2M	$2M
Rev. Growth	-1.8%	-1.0%
EPS	$-0.04	$-0.02
EPS Growth	+59.3%	+37.1%
P/E	—	—

What’s Driving the Stock

1Recent contract win with a major nuclear facility expected to increase revenue by 25% over the next year.
2Development of a new radiation detection technology that reduces costs by 30% is nearing commercialization.
3Partnership with a leading medical technology firm to integrate radiation detection into their products.
4Potential regulatory changes favoring nuclear energy could lead to increased demand for UCLE's products.
5Increased focus on nuclear energy as a clean energy source
6Advancements in radiation detection technology
7Changes in nuclear energy regulations impacting demand for detection equipment
8Technological advancements in radiation detection technology

FY2025 Snapshot

Revenue: $2M
Rev. Growth: -1.0%
Gross Margin: 50.3%
Op. Margin: -64.5%
Net Margin: -57.1%
Net Income: $-1M
NI Growth: +28.8%
EPS: $-0.02
1Y Return: +39.5%

UCLE Chart

My Notes

"We are poised for significant growth as the nuclear sector evolves and regulatory support increases."
Moat: UCLE's competitive advantage is bolstered by its proprietary technology and established relationships within the nuclear sector.
growth - Investors seeking exposure to niche technology markets with potential for high returns.
Interest rates affect UCLE primarily through the cost of financing for R&D and capital expenditures…
Watch on earnings: Regulatory changes in the nuclear sector, R&D expenditure as a percentage of revenue, Partnership announcements with nuclear facilities.

One Sentence Summary:

US Nuclear: the setup is constructive — recent contract win with a major nuclear facility expected to increase revenue by 25% over the next year.

Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.

Writing up the research note…

First read for a new ticker takes about 20–30 seconds while we build the analysis from the latest fundamentals, estimates, and intelligence. It's saved after this, so future visits are instant.

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance

Metric

FY2024

FY2025

P/E

—

What’s Driving the Stock

1Recent contract win with a major nuclear facility expected to increase revenue by 25% over the next year.

2Development of a new radiation detection technology that reduces costs by 30% is nearing commercialization.

3Partnership with a leading medical technology firm to integrate radiation detection into their products.

4Potential regulatory changes favoring nuclear energy could lead to increased demand for UCLE's products.

5Increased focus on nuclear energy as a clean energy source

6Advancements in radiation detection technology

7Changes in nuclear energy regulations impacting demand for detection equipment

8Technological advancements in radiation detection technology

My Notes

"We are poised for significant growth as the nuclear sector evolves and regulatory support increases."

Moat: UCLE's competitive advantage is bolstered by its proprietary technology and established relationships within the nuclear sector.

growth - Investors seeking exposure to niche technology markets with potential for high returns.

Interest rates affect UCLE primarily through the cost of financing for R&D and capital expenditures…

Watch on earnings: Regulatory changes in the nuclear sector, R&D expenditure as a percentage of revenue, Partnership announcements with nuclear facilities.